Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | GMNN | O75496 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | BLM | P54132 | 2/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
| ▸ | CMKLR1 | Q99788 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29875233 | 1.00 | ALDH1A1 (0.64) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL9857065 | 0.95 | MEN1 (0.62) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL7913756 | 0.93 | MEN1 (0.60) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL15655785 | 0.93 | MEN1 (0.60) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL15658636 | 0.93 | MEN1 (0.60) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL15659633 | 0.93 | MEN1 (0.60) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL15732279 | 0.93 | MEN1 (0.60) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL11352446 | 0.93 | MEN1 (0.60) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL10798233 | 0.92 | MEN1 (0.59) | ALDH1A1MAPTHPGDKDM4EMEN1 | |
| SCHEMBL28376839 | 0.92 | MEN1 (0.59) | ALDH1A1MAPTHPGDKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8378216-B2 | Energy cable | PRYSMIAN S.P.A. (IT) | 2013-02-19 | — | — | US | claimed |
| CN-101548340-B | Energy cable | PRYSMIAN CO LTD | 2013-01-30 | — | — | CN | claimed |
| US-20100126756-A1 | ENERGY CABLE | PRYSMIAN CAVIESISTEMI ENERGIA (IT) | 2010-05-27 | — | — | US | claimed |
| CN-101548340-A | Energy cable | PRYSMIAN CO LTD | 2009-09-30 | — | — | CN | claimed |
| EP-2092535-A1 | ENERGY CABLE | Prysmian S.p.A. (IT) | 2009-08-26 | — | — | EP | claimed |
| WO-2008058572-A1 | ENERGY CABLE | PRYSMIAN S.P.A. (IT) | 2008-05-22 | — | — | WO | claimed |
| CN-114956933-A | Marker containing isotope oxygen atom and preparation method and application thereof | 清华大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-105754099-B | Composition and polymer | 旭化成株式会社 | 2018-09-18 | — | — | CN | disclosed |
| EP-2092535-B1 | ENERGY CABLE | PRYSMIAN SPA (IT) | 2017-01-18 | — | — | EP | disclosed |
| CN-103502315-A | Composition and polymer | ASAHI KASEI CHEMICALS CORP | 2014-01-08 | — | — | CN | disclosed |
| US-8378216-B2 | Energy cable | PRYSMIAN S.P.A. (IT) | 2013-02-19 | — | — | US | disclosed |
| CN-101548340-B | Energy cable | PRYSMIAN CO LTD | 2013-01-30 | — | — | CN | disclosed |
| US-20100126756-A1 | ENERGY CABLE | PRYSMIAN CAVIESISTEMI ENERGIA (IT) | 2010-05-27 | — | — | US | disclosed |
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | PROSIDION LIMITED (GB) | 2009-09-03 | — | — | US | disclosed |
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | PROSIDION LIMITED (GB) | 2009-09-03 | — | — | US | disclosed |
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | PROSIDION LIMITED (GB) | 2009-09-03 | — | — | US | disclosed |
| EP-2092535-A1 | ENERGY CABLE | Prysmian S.p.A. (IT) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008058572-A1 | ENERGY CABLE | PRYSMIAN S.P.A. (IT) | 2008-05-22 | — | — | WO | disclosed |
| CN-1027064-C | Naphthalene derivatives | EISAI CO LTD (JP) | 1994-12-21 | — | — | CN | disclosed |
| CN-1043696-A | NAPHTHALENE DERIVATIVES | EISAI CO LTD (JP) | 1990-07-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | TPH1, HTR3B, HTR1A | ALDH1A1 195/4885MAPT 891/4885HPGD 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.